Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab—IL PSO (Italian Landscape Psoriasis). - Trovato, Emanuele; Cartocci, Alessandra; Gaiani, Francesca; Messina, Francesco; Mastorino, Luca; Macagno, Nicole; Carugno, Andrea; Campoli, Marco; Fargnoli, Maria Concetta; Lora, Viviana; Rossi, Agnese; Gioacchini, Helena; et al. (Dermatology & Therapy, 2026)